Previous Article | Next Article ![]()
Infect Immun, June 1998, p. 2996-2998, Vol. 66, No. 6
Laboratory for Biological and Chemical
Sciences, Department of Chemistry, Georgia State University, Atlanta,
Georgia
Received 10 February 1998/Returned for modification 13 March
1998/Accepted 26 March 1998
Cryptococcus neoformans NIH 409 was cultured in a
defined medium containing D-[1-13C]xylose
(Xyl), D-[1-13C]mannose (Man), or
D-[1-13C]mannitol as the sole carbon source.
The distribution of 13C in the Man, Xyl, glucuronic acid
(GlcA), and O-acetyl constituents of native and de-O-acetylated
glucuronoxylomannan (GXM) was determined by one-dimensional
13C nuclear magnetic resonance spectroscopy. The
carbon chain of Man was incorporated intact into GXM since
13C was observed only in carbon 1 of Man, GlcA, and Xyl.
The carbon chain of mannitol was incorporated intact into GXM since
13C was observed only in carbons 1 and 6. This was expected
since mannitol has an axis of symmetry. The carbon chain of Xyl was identified only in carbons 1 and 3 of Man, GlcA, and Xyl. This pattern
of labeling is consistent with the assimilation of Xyl through the
pentophosphate pathway.
Cryptococcus neoformans
is an opportunistic fungal pathogen that causes a life-threatening
disease, cryptococcosis, in immunocompromised individuals (7, 9,
10). Disseminated cryptococcosis is a leading cause of death
among patients with AIDS (9, 11). Glucuronoxylomannan (GXM)
consists of a linear (1 A stock culture (10 ml) of C. neoformans 409, serotype B
(1), was prepared by using a chemically defined standard
liquid medium containing natural-abundance glucose (5, 12).
This culture (0.2 ml) was used to inoculate a second aliquot (10 ml) of
defined medium. After 48 h, the culture was centrifuged
(5,000 × g for 5 min); the cells were resuspended in
prechilled, glucose-free medium, and the centrifugation was repeated.
This procedure was repeated three times to remove as much of the
natural-abundance glucose as feasible. The washed cells were suspended
in fresh medium (25 ml) containing 500 mg of [1-13C]Man
(Cambridge Isotope Laboratories, Inc.). After 5 days, the culture was
autoclaved for 25 min at 121°C, the cells were removed by
centrifugation at 18,000 × g for 1 h, and the
supernatant fluid was reserved. The pellet was washed with distilled
water (3 ml), and the centrifugation was repeated. The combined culture
supernatant fluid and wash (~25 ml) was adjusted to 0.2 M NaCl,
and 0.75 g of hexadecyltrimethylammonium bromide was added
to the stirred solution at 23°C. A 0.05% solution of
hexadecyltrimethylammonium bromide (50 ml) was added slowly with
stirring, and the precipitate was recovered by centrifugation at
5,000 × g for 15 min at 23°C. The pellet was
triturated with 10% ethanol, and the suspension was centrifuged as
described above. The pellet was dissolved in 1 M NaCl (12 ml) by
stirring overnight or until the precipitate was completely dissolved.
GXM was precipitated by slowly adding 3 volumes of 95% ethanol, and
the flask was placed at 4°C. The GXM was recovered by centrifugation
at 5,000 × g for 15 min at 4°C. The GXM was
dissolved in 1 M NaCl (~12 ml) with stirring until it was completely
dissolved. The solution was treated by ultrasonic irradiation (Branson
450 Sonifier) at 80% power and a 40% pulse under nitrogen for 2 h below 20°C, dialyzed, and lyophilized (69 mg; 13.8% yield, based
on the amount of glucose added). A portion of the GXM was
O-deacetylated at pH 11.5 (NH4OH) for 24 h at 23°C,
dialyzed, and lyophilized (4, 5). A similar procedure was
used to prepare GXM from [1-13C]mannitol (9% yield) or
[1-13C]Xyl (3.8% yield; one-half scale and 15-day
culture) as the sole carbon source.
GXM or O-deacetylated GXM (9 to 20 mg) was exchanged twice in 99.96%
D2O (Isotec Inc.) with intermediate lyophilization. The sample was dissolved in 0.70 ml of 99.96% D2O and
transferred into a 5-mm NMR tube (Wilmad 535-PP). All NMR experiments
were performed at 60°C on a Varian 400 VXR spectrometer equipped with a 5-mm switchable probe operated at 100.58 MHz for 13C. The
spectral width was 25 kHz, and 1,000 data points were collected at 10-s
intervals. The data were processed off line by using the FELIX 95.0 software package (Biosym/Molecular Simulations, San Diego, Calif.) on a
Silicon Graphics Indy workstation. 13C chemical shifts were
measured relative to that of sodium
4,4-dimethyl-4-silapentane-1-sulfonate, which was taken as 0.00 ppm.
The NMR spectrum of the O-deacetylated GXM obtained from the experiment
using D-[1-13C]Man as the sole carbon source
showed that the carbon chain of Man was not altered by the yeast during
its conversion to the intermediates required for the synthesis of GXM
(UDP-GlcA, UDP-Xyl, and GDP-Man) (16, 17). Figure
1a shows that only the anomeric carbon
atoms of the three saccharide constituents of GXM are labeled (13). This is consistent with the usual pathways for the
assimilation of Man. The NMR spectrum of the O-deacetylated GXM
obtained from the experiment using
D-[1-13C]mannitol as the sole carbon source
showed that the carbon chain of mannitol was not altered by the yeast.
Figure 1b shows that only the anomeric center (carbon 1) and carbon 6 of the three saccharide constituents of GXM were labeled
(13). The carbonyl carbon of GlcA is not shown in Fig. 1b,
but it is clearly visible at 178.8 ppm in Fig.
2b (13). Mannitol has an axis
of symmetry that makes carbons 1 and 6 indistinguishable during its
assimilation. This is consistent with the usual pathways for the
assimilation of mannitol. O-deacetylated GXM obtained from the
experiment using D-[1-13C]Xyl as the sole
carbon source showed that the carbon chain was not incorporated intact
by the yeast. Figure 1c shows that only the anomeric carbon and carbon
3 of the three saccharide constituents of GXM are labeled
(13). This is consistent with the assimilation of Xyl
through the pentophosphate pathway (hexose monophosphate shunt). NMR
analysis of the three native GXMs showed that the methyl of the
O-acetyl substituent was labeled (Fig. 2a, b, and c, 23.1 ppm). The carboxyl carbonyl of GlcA was labeled when
[1-13C]mannitol was the sole carbon source (Fig. 2b,
177.8 ppm). These results are consistent with the data discussed above.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Assimilation of Xylose, Mannose, and Mannitol for
Synthesis of Glucuronoxylomannan of Cryptococcus neoformans
Determined by 13C Nuclear Magnetic Resonance
Spectroscopy
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
3)-
-D-mannopyranan bearing
-D-xylopyranosyl (Xyl),
-D-glucopyranosyluronic acid (GlcA), and
6-O-acetyl substituents (2, 6, 12-15). Mannitol is a major metabolite of the yeast, and it and GXM are considered major
virulence factors (3, 8). C. neoformans can use
Xyl, mannose (Man), and mannitol as a sole carbon source, but the
biochemical pathways for their incorporation into GXM produced in a
chemically defined medium have not been determined. The assimilation of
[1-13C]Xyl, [1-13C]Man, and
[1-13C]mannitol was studied by determining the
distribution of 13C in the saccharide residues of purified
GXM by one-dimensional 13C nuclear magnetic resonance
spectroscopy (NMR).

View larger version (27K):
[in a new window]
FIG. 1.
Proton-decoupled 13C NMR spectra of
O-deacetylated GXM. a, [1-13C]Man; b,
[1-13C]mannitol; c, [1-13C]Xyl. The
chemical shifts of the carbon atoms detected are as follows: C-1,
~102 to 106 ppm; C-3, 77 to 80 ppm; C-6, 63 ppm.

View larger version (15K):
[in a new window]
FIG. 2.
Proton-decoupled 13C NMR spectra of native
GXM. a, [1-13C]Man; b, [1-13C]mannitol; c,
[1-13C]Xyl. The chemical shifts of the carbon atoms
detected are as follows: carbonyl (carboxyl of GlcA and O-acetyl), 180 ppm; C-1, ~102 to 106 ppm; C-3, 77 to 80 ppm; C-6, 63 ppm; methyl
(O-acetyl), 21 ppm.
In summary, the carbon chain of Man was incorporated intact into GXM since 13C was observed only in carbon 1 of Man, GlcA, and Xyl. The carbon chain of mannitol was incorporated intact into GXM since 13C was observed only in carbons 1 and 6 of the GXM sugar residues. This was expected since mannitol has an axis of symmetry. The carbon chain of Xyl was identified only in carbons 1 and 3 of Man, GlcA, and Xyl. This pattern of labeling is consistent with the assimilation of Xyl through the pentophosphate pathway (hexose monophosphate shunt). This study illustrates the use of 13C-labeled monosaccharides for the tracing of their assimilation and incorporation into capsular polysaccharides. The preparation of GXMs specifically enriched with 13C (13) will be useful for defining conformation models of these important antigenic polysaccharides (18, 19).
| |
ACKNOWLEDGMENTS |
|---|
This research was supported in part by Public Health Service grant AI 31769 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Chemistry, Georgia State University, University Plaza, Atlanta, GA 30303. Phone: (404) 651-3868. Fax: (404) 651-1416. E-mail: cherniak{at}gsu.edu.
Present address: Department of Chemistry, Rutgers University,
Piscataway, N.J.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Belay, T., R. Cherniak, E. B. O'Neill, and T. R. Kozel. 1996. Serotyping of Cryptococcus neoformans by dot enzyme assay. J. Clin. Microbiol. 34:466-470[Abstract]. |
| 2. | Bhattacharjee, A. K., J. E. Bennett, and P. J. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624[Medline]. |
| 3. |
Bulmer, G. S., and M. D. Sans.
1968.
Cryptococcus neoformans. III. Inhibition of phagocytosis.
J. Bacteriol.
95:5-8 |
| 4. | Cherniak, R., L. C. Morris, and S. A. Meyer. 1992. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohydr. Res. 225:331-337[Medline]. |
| 5. |
Cherniak, R.,
L. C. Morris,
B. C. Anderson, and S. A. Meyer.
1991.
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.
Infect. Immun.
59:59-64 |
| 6. |
Cherniak, R., and J. B. Sundstrom.
1994.
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
Infect. Immun.
62:1507-1512 |
| 7. | Diamond, R. D. 1995. Cryptococcus neoformans, p. 2331-2340. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingston, New York, N.Y. |
| 8. | Fromtling, R. A., H. J. Shadomy, and E. S. Jacobson. 1982. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79:23-29[Medline]. |
| 9. | Kovacs, A. J., A. A. Kovacs, M. Polis, C. Wright, V. J. Gill, C. U. Tuazon, E. P. Gelmann, H. C. Lane, R. Longfield, G. Overturf, A. M. Macher, A. S. Fauci, J. E. Parrillo, J. E. Bennett, and H. Masur. 1985. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:533-538. |
| 10. | Kwon-Chung, K. J., and J. E. Bennett. 1992. In Medical mycology, p. 397-446. Lea & Febiger, Malvern, Pa. |
| 11. | Powderly, W. G. 1992. Therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 14(Suppl. 1):S54-S59. |
| 12. | Sheng, S., and R. Cherniak. 1997. Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy. Carbohydr. Res. 301:33-40[Medline]. |
| 13. | Skelton, M. A., H. van Halbeek, and R. Cherniak. 1991. Complete assignment of the 1H and 13C N.M.R. spectra of the de-O-acetylated glucuronoxylomannan from Cryptococcus neoformans serotype B. Carbohydr. Res. 221:259-268[Medline]. |
| 14. | Turner, S. H., and R. Cherniak. 1991. Multiplicity in the structure of the glucuronoxylomannan of Cryptococcus neoformans, p. 123-142. In J. P. Latgé, and D. Boucias (ed.), Fungal cell wall and immune response. Springer-Verlag, Berlin, Germany. |
| 15. | Turner, S. H., and R. Cherniak. 1991. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C nuclear magnetic resonance spectroscopy. Carbohydr. Res. 211:103-116[Medline]. |
| 16. | White, C. W., R. Cherniak, and E. S. Jacobson. 1990. Side group addition by xylotransferases and glucuronyltransferase in biosynthesis of capsular polysaccharide of Cryptococcus neoformans. J. Med. Vet. Mycol. 28:289-301[Medline]. |
| 17. | White, C. W., and E. S. Jacobson. 1993. Mannosyl transfer in Cryptococcus neoformans. Can. J. Microbiol. 39:129-133[Medline]. |
| 18. | Xu, Q., and A. Bush. 1996. Dynamics of uniformly 13C-enriched cell wall polysaccharide of Streptococcus mitis J22 studied by 13C relaxation rates. Biochemistry 35:14512-14520[Medline]. |
| 19. | Xu, Q., and A. Bush. 1996. Molecular modeling of the flexible cell wall polysaccharide of Streptococcus mitis J22 on the basis of heteronuclear NMR coupling constants. Biochemistry 35:14521-14529[Medline]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»